Telix Pharmaceuticals Ltd
TLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002007191
No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.
Other share classesTLPPF
Q1 2025 vs. Q4 2024
How the institutions holding Telix Pharmaceuticals Ltd changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 1 | 6 | +5 |
| Shares | 3.73K | 47.6K | +43.9K (+1,177.4%) |
| Value | $57.4K | $798.6K | +$741.1K (+1,290.2%) |
New holders (5)
Institutions that held Telix Pharmaceuticals Ltd at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Abc Arbitrage SA | 26,939 | $451.5K | 0.08% |
| Private Advisor Group, LLC | 10,140 | $169.9K | 0.00% |
| Morgan Stanley | 5,634 | $94.4K | 0.00% |
| Rhumbline Advisers | 1,146 | $19.2K | 0.00% |
| EverSource Wealth Advisors, LLC | 137 | $2.30K | 0.00% |
Sold out (0)
Institutions that held Telix Pharmaceuticals Ltd at the end of Q4 2024 and filed for Q1 2025 without it.
None.